Prevalence of co-morbidities in a Hellenic COPD population (COMPACT study) Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017
Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006
COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015
Prevalence of comorbidities in patients with COPD in south-Spain Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Prevalence of cardiovascular disease in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010
LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013
Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011 Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013
Prevalence and risk factors of co-morbidities in subjects with mild and moderate COPD detected by screening Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013
High prevalence of undiagnosed COPD in patients with cardiovascular disease Source: Annual Congress 2009 - Risk factors for COPD Year: 2009
Socioeconomic position and use of drugs in chronic obstructive pulmonary disease (COPD): A population-based cohort study in Rome, Italy Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
Does Nutritional Risk Screening 2002 correlate with dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study. Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
Five-year follow-up of subjects diagnosed with COPD in a South African burden of obstructive lung disease (BOLD) survey Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014
The severity of anxiety in COPD patients (pts) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014
Extent and impact of late vs early stage COPD diagnosis in the Swedish ARCTIC study Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013